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The distribution of left ventricular hypertrophy was as-
sessed by M-mode and two-dimensional echocardiog-
raphy in 89 patients with hypertrophic cardiomyopathy.
Myocardial thickness was measured in the septum and
the free and posterior wall in both the proximal and
distal left ventricle. All patients had at least one myo-
cardial region that was hypertrophied. The predominant
pattern of hypertrophy was defined as symmetr ic (31%),
asymmetric septal (55% ) and distal ventricular (14%).
The spectrum of wall thickness measurements between
patients with symmetric hypertrophy was wide (1.5 to
4.5 em) and was not related to age. In patients with
asymmetric septal hypertrophy, the distribution of hy-
pertrophy conformed to previously described patterns;
hypertrophy was localized to the anterior septum (14%)
Hypertrophic cardiomyopathy is defined as a heart muscle
disorder of unknown origin that is characterized by unex-
plained hypertrophy of a nondilated left ventricle ( I). During
the past decade, the most widely applied diagnostic criteria
were derived from the M-mode echocardiogram. These cri-
teria emphasized the demonstration of asymmetric hyper-
trophy between the upper anterior septum and the left ven-
tricular posterior wall as well as features associated with
Icft ventricular pressure gradients, such as systolic anterior
motion of the mitral valve and mid-systolic closure of the
aortic valve. Recent studies, however, have shown that
myocardial regions that are not visualized by the M-mode
beam may be hypertrophied in the absence of asymmetric
septal hypertrophy (2,3). Thus, using the M-mode tech-
nique, the diagnosis and pattern of myocardial hypertrophy
may be undetected. Two-dimensional echocardiography
permits evaluation of the entire left ventricle (4- 6). The
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or the anterior and posterior septum (35%) or involved
both the septum and the left ventricular free wall (51%).
The patients with distal ventricular hypertrophy had
marked papillary muscle thickening, and only 1 of 12
patients could be correctly diagnosed using M·mode
echocardiography ,
The proportion of patients with symmetr ic and distal
ventricular hypertrophy was greater than that reported
when patients are selected on the basis of M-mode di-
agnostic criteria. This reflects the limitations of the M-
mode technique in the assessment of left ventricular hy-
pertrophy and suggests that the recognition and under-
standing of hypertrophic cardiomyopathy have been
biased by patients with asymmetric septal hypertrophy
who previously were most readil y identified.
purpose of this study was to use two-dimensional echo-
cardiography to assess the regional distribution of left ven-
tricular hypertrophy in patients with hypertrophic cardio-
myopathy.
Methods
Study Patients
One hundred five patients with hypertrophic cardio-
myopathy were studied by two-dimensional echocardiog-
raphy between November 1981 and July 1982. Of these 105
patients. 89 had adequate recordings. Of the 89, 46 were
male and 43 were female with an age range of 9 to 70 years
(mean 39) at the time of study. Seventy-nine of those studied
were consecutive patients who had been followed up at the
Hammersmith Hospital for I to 20 years (mean 6). The
diagnosis of hypertrophic cardiomyopathy was made in the
remaining 10 patients during the period of study. In all
patients, this was based on clinical (7) and angiographic (8)
or echocardiographic (9) demonstration of unexplained left
ventricular hypertrophy. None of these patients had docu-
mented high blood pressure, abnormal renal function or
ocular changes of systemic hypertension.
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Figure 1. Diagrammatic representation of two echographic left
ventricular cross sections. Quadrant measurements are shown by
arrows. Ao = aorta; AVS and PVS = anterior and posterior
ventricular septum, respectively; LA = left atrium; LV = left
ventricle; PW and FW = posterior and free wall, respectively.
ventricle at the level of the mitral valve tips (the portion
usually sampled by the M-mode echocardiographic beam)
and the second toward the apex at a level below the papillary
muscles (Fig. 1). Measurements were made at end-diastole
(maximal cavity size) after careful localization of epicar-
dium and endocardium using normal and slow forward play-
back. Wall thickness was measured at the quadrants (Fig.
I) and the thickness of the apical myocardium was measured
in the four chamber apical view. The papillary muscles were
assessed by studying all views and then grading their hy-
pertrophy as absent, mild (larger than normal but not elim-
inating the lower cavity) or severe (producing lower cavity
elimination) .
For the purpose of analysis, this sample was divided into
three groups: 1) patients with asymmetric septal hypertro-
phy, that is those with a ratio of anterior or posterior septum
to left ventricular posterior wall of 1.5: 1 or greater in the
upper or lower ventricle; 2) patients with predominantly
distal ventricular hypertrophy, defined as a ratio of 1.5:1 or
greater in at least two of four measurements comparing
lower and upper ventricular wall thickness; and 3) patients
with symmetric hypertrophy, that is, those with neither of
the above, in whom the coefficient of variation for the mea-
surements of left ventricular myocardial thickness was less
than 20%.
Reliability and reproducibility of the measurements.
Reliability was assessed by reanalyzing the original echo-
cardiographic recordings of 20 patients without knowledge
of the original measurements or the frames from which they
Cardiac catheterization was performed in 71 patients and
50 had a left ventricular pressure gradient of 20 mm Hg or
greater measured at rest or on provocation (first with iso-
prenaline infusion and later with amyl nitrate inhalation and
the Valsalva maneuver). Of the patients who did not undergo
catheterization, 12 had clinical and M-mode echocardio-
graphic features of hypertrophy and a left ventricular pres-
sure gradient (9) and 6 had unexplained electrocardiographic
and M-mode echocardiographic evidence of left ventricular
hypertrophy and a family history of hypertrophic cardio-
myopathy,
Control subjects. Twenty-five normal volunteers (mean
age 43 years, range 18 to 61; 16 male and 9 female) under-
went similar echocardiographic study,
Echocardiography
Apparatus. Each patient was studied with a combina-
tion ofM-mode and wide angle (90°) two-dimensional echo-
cardiography at 8, 12, 16 and 24 em depths using a 2.5 or
3.5 MHz transducer with a Hewlett-Packard phased array
(model 77020A) or an ATL mechanical sector (MI) ultra-
sound scanner. Images were stored on a Sony Betamax video
recorder (model 323). Single frozen still frames were pho-
tographed directly.
Techniques. A complete M-mode and two-dimensional
study was performed and recorded on video tape and in-
cluded parasternal long-axis and multiple short-axis views
of the left ventricle with the transducer positioned at the
fourth intercostal space, Great care was taken to make an
accurate short-axis left ventricular sweep from aortic root
to apex ensuring an approximately circular cavity through-
out; this occasionally required inferolateral movement of
the transducer. M-mode recordings of the septum, posterior
wall, cavity size and mitral and aortic valves were obtained
by identifying the relevant structure in a short-axis para-
sternal view with an M-mode cursor displaying this portion
of the sector. Two- and four-chamber views were obtained
with the transducer at the apex.
Echocardiographic interpretation. The M-mode re-
cordings were studied for the presence of mid-systolic clo-
sure of the aortic valve, systolic anterior motion of the mitral
valve (graded as severe if there was systolic apposition of
the mitral valve and septum, mild if there was no apposition,
or absent) and asymmetric septal hypertrophy (upper an-
terior septal to posterior wall ratio of 1.5:1 or greater).
Asymmetric septal hypertrophy with a ratio of 1.3:1 or
greater was also considered. Of the classic echocardio-
graphic features of hypertrophic cardiomyopathy (9), these,
as well as wall thickness measurements, were assessed.
Systolic and diastolic cavity dimensions (em) were mea-
sured at minimal cavity size and at the onset of the R wave
of the electrocardiogram, respectively.
From the two-dimensional echocardiogram, two short-
axis scans were used for analysis, one in the upper left
lower left
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Echocardiogram
SAM = systolic anterior motion of the mitral valve.
Table 1. Reliability and Reproducibility of Echocardiographic
Measurements: Retest Reliability Coefficients
were made. Reproduc ibility was determined in 20 unse-
lected patients by comparing the original measurements with
those made from a repeat echocardiographic study that was
performed I to 6 months later.
Statistical analysis. Values are quoted as the mean ±
I standard deviation. The scatter of values was expressed
as the coefficient of variation, that is (standard deviation -
mean) x 100. The Student' s t or chi-square test was used
Distribu tion of Left Ventricular Hypertrophy (Tables
2 and 3)
All patients (Fig. 2 to 5). In all patients, at least one
wall thickness measurement exceeded 2 standard deviations
from the normal (greater than 1.4 cm). Such minimal left
ventricul ar hypertrophy was present in four patients and
exceeded this value in the others. The mean ratio of upper
anterior septum to posterior wall thickness was 1.5 ± 0.5.
In comparison with normal subjects, the mean wall thick-
nesses for all left ventricul ar regions were greater (proba-
bility [p] < 0.00 1) and left ventr icular cavity dimensions
were decreased (p < 0.00 I).
The thickest region was the upper anterior septum in 32
patients (36%) , the lower anterior septum in 18 (20%) , the
upper posterior septum in 12 (14%), the lower posterior
septum in 8 (9%) and the upper or lower free wall in 19
(21%). In 35 patients (40%), the lower anterior septum was
for analyzing the differences between variables. For the
assessment of reliability and reprodu cibility, a retest relia-
bility coefficient was calculated; this assumed an ideal value
of unity .
Results
Reliability and reproducibility (Table 1). The relia-
bility and reproducibility of the M-mode and two-dimen-
sional measurements made perpendicular to the ultrasound
beam were excellent. Two-dimensional measurements made
lateral to the ultrasound beam were less so; apical thickness
measurements were, therefore , excluded from the subse-
quent analysis.0 .95 0.93
0.92 0.90
0.92 090
094 0.91
0.93 0.92
0.86 0.8 1
0.90 089
0.92 0.90
0.73 067
Same Repeat
096 0.95
0.96 0.94
0.95 0.94
0.95 0.93
0.99 092
0.98 0.91
Echocardiograph ic Measurement
M-mode
Septum
Posterior wall
Diastolic dimension
Systolic dimension
SAM
Mid-systolic closure of aortic
valve
Two-dimensional
Upper left ventricle
Anterior ventricular septum
Posterior ventricular septum
Free wall
Postenor wall
Lower left ventncle
Anterior ventricular septum
Posterior ventricular septum
Free wall
Posterior wall
Apical myocardium
Table 2. Left Ventricular Dimension and Wall Thickness Measurements
Patients With Hypertrophic Cardiomyopathy
Asymmetnc Distal
Septal Ventricular Symmetnc Normal
Total Group Hypertrophy Hypertrophy Hypertrophy Subjects
(n=89) (n = 49) (n = 12) (n = 28) (n = 25)
Upper left ventricle
Ratio VS/posterior wall 1.5 ± 0.5* I 9 ± 0.4* 1.2 ± 0 2 1.2 ± 0 2 1. 1 ± 0.2
Anterior VS 1.8 ± 0.5* 1.9 ± 0.5* I 4 ± O.4t 1.6 ± 0.6* 0.9 :!: 0 .2
Posterior VS 1.7 ± 0.5* 1.7 ±04 1.5 :!: 0 .5* 1.6 :!: 0 .5* 0.8 ± 03
Free wall 1.5 ± 0.4* 1.5 ± 0.4 * 1.3 :!: 0 .5t 1.6 :!: 0 .5* 0.8 ± 0.3
Posterior wall 1.2 ± 0.5* I.I :!: 0.2 1.2 :!: 0 4t I 5 :!: 0. 7* 0.8 ± 0.2
Lower left ventricle
Anterior VS 1.7 ± 06* I 7 ± 0.6* 2.3 ± 0.8* I 6 ± 0.6* 0.9 ± 0.2
Posterior VS 1.6 ± 0.5* 1.5 ± 0.3* 2.2 ± 0.8* 1.5 ± 05* 1.0 ± 02
Free wall 1 5 ± 0.6* 1.3 ± 0.3* 22 :!: 0.7* 1.5 ::': 0 .6* 1 0 ± 0. 1
Posterior wall 1.5 :!: 0 .6* 1.3 ± 0.5* 1.9 ± 0.6* I 6 ± 0.6* 1.0 ± 0 .2
LV diastolic dimension 4. 1 :!: 0.8* 4. 1 ± 0.7t 4.0 :!: 0 .8:\: 4 . 1 :!: 09§ 4 .5 :!: 0 .3
LV systolic dimension 2.6 ± 0.7:\: 2.6 == 0.6:\: 2.7 :!: 0.9 2.5 ± 0.8§ 2.9 ± 0 5
*probability (p) < 0.00 1; tp < 0.00 5; :\:p < 0.01; §p < 0.05 (differences from normal). All measurements are mean ± 1 standard deviation (cm).
LV = left ventricular: VS = ventricular septum
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Table 3. Number of Patients With Systolic Anterior Motion of the Mitral Valve, Mid-Systolic Closure of the Aortic Valve and
Papillary Muscle Hypertrophy in Relation to the Pattern of Left Ventricular Hypertrophy
Panents With Hypertrophic Cardiomyopathy
Asymmetnc Distal
Total Septal Ventricular Symmetric
Group Hypertrophy Hypertrophy Hypertrophy
(n=89) (n=49) (n= 12) (n=28)
Systohc anterior motion of the
mitral valve (n = 42)
Severe/mild/absent 27/15/47 16/12/21 2/1/9 9/2117
Mid-systolic closure of the aortic
valve (n = 41 of 69)
Present/absent 41128 23114 4/7 14/7
Papillary muscle hypertrophy (n
= 85)
Severe/mild/absent 58127/4 31116/2 9/2/1 18/9/1
thicker than the upper anterior septum. The lower free wall
was thicker than the upper in 42 patients (47%) and the
thickness of the upper or lower free wall exceeded that in
the upper anterior septum in 28 patients (31%).
Systolic anterior motion of the mitral valve was detected
in 42 patients (47%) and mid-systolic closure of the aortic
valve was observed in 41 (59%) of69 patients. Of the classic
M-mode features that were assessed, 21 patients (24%) had
all three features, 42 patients (47%) had two and 69 patients
(78%) had only one feature.
Asymmetric septal hypertrophy (Fig. 2). Forty-nine
patients who had a ratio of septum to posterior wall thickness
of 1.5: 1 or greater in the upper or lower left ventricle were
designated as having asymmetric septal hypertrophy. Within
this group, asymmetric septal hypertrophy was present in
all septal regions in 2 patients, three septal regions in 6, the
upper anterior and posterior septum in 17, the upper and
Figure 2. Parasternal long-axis view of a patient with asymmetric
septal hypertrophy, showing disproportionate thickening of the
upper septum.
lower anterior septum in 5 patients and in a single septal
region in 19 patients. Forty (82%) of the 49 patients had
asymmetric septal hypertrophy of the upper anterior septum;
in 22 patients (45%) this was the thickest myocardial region.
This region was thicker than the upper posterior septum in
31 patients (63%) and the lower anterior and posterior sep-
tum in 25 patients (51%). Hypertrophy was confined to the
anterior septum in seven patients (14%) and to the upper
anterior septum alone in five patients. In 17 patients (35%),
hypertrophy was present only in the anterior and posterior
septum (three or four septal regions in 8 patients and two
septal regions in 9).
Twenty-jive patients (51%) had hypertrophy of both the
septum and the free wall. In these 25 patients, the thickest
region was the septum in 16 patients and the free wall in
4; in 5 patients, the septum and free wall were of approx-
imately equal thickness. Hypertrophy was present in three
or four septal regions in 17 patients, in two regions in 6
patients and in one region in 2 patients.
Left ventricular cavity dimensions were similar to those
of the complete group, but significantly different from those
of the normal group. Systolic anterior motion of the mitral
valve was present in 28 patients (57%) and mid-systolic
closure of the aortic valve was noted in 23 (62%) of 37
patients.
Distal ventricular hypertrophy (Fig. 3). A ratio of 1.5:1
or greater comparing myocardial thickness in the lower and
upper left ventricle was present in the anterior septum in
13 patients (15%), the posterior septum in 4 (5%), the left
ventricular posterior wall in 22 (25%) and the free wall in
7 patients (8%). This ratio was present in two of these areas
in 12 patients and they were designated as having distal
ventricular hypertrophy. If a ratio of 1.3:1 or greater had
been used, seven additional patients would have been in-
cluded within this group. Hypertrophy was absent or mild
in the upper left ventricle; however, measurements of wall
thickness in the lower cavity were grossly increased and 11
JACC Vol 2, No 3
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Figure 3. Parastemallong-axis (top) and short-axis (middle and
bottom) view of a patientwithdistal ventricular hypertrophy, The
upper ventricular wall thickness in the portion sampled by the M-
mode beams is relatively normal (top and middle), but there is
gross distal ventricular hypertrophy (bottom),
of the 12 patients had hypertrophy of the papillary muscles
that resulted in lower cavity elimination.
Six of the patients with distal ventricular hypertrophy
also had asymmetric septal hypertrophy, which was con-
fined to the lower anterior or posterior septum in three pa-
tients and to the upper posterior septum in two patients. In
the remaining patient, asymmetric septal hypertrophy was
present in all four septal regions, but the predominant pattern
of hypertrophy was distal ventricular because the ratio of
lower to upper wall thickness was 1.5: I for both anterior
and posterior septum and 1.7: 1 for the left ventricular pos-
terior wall and free wall. Systolic anterior motion of the
mitral valve was seen in 3 patients (35%) and mid-systolic
closure of the aortic valve in 4 (36%) of 11 patients; all of
these patients also had asymmetric septal hypertrophy.
Symmetric hypertrophy (Fig. 4 and 5). Twenty-eight
patients who did not have asymmetric septal or distal ven-
tricular hypertrophy and who had a coefficient of variation
for the measurements of myocardial thickness of less than
20% fulfilled the criteria for symmetric hypertrophy. If the
criteria of asymmetry had been a ratio of 1.3:1 rather than
1.5:1, 11 of these patients would not have been included in
this group. In patients with symmetric hypertrophy, mea-
surements of wall thickness were significantly thicker (p <
0.001) over a wide range (1.4 to 4.5 ern). The degree of
hypertrophy was not related to age. The variation in the
measurements of wall thickness within individual patients,
was similar in those with symmetric hypertrophy and in the
normal subjects, but was significantly less than in patients
with asymmetric septal and distal ventricular hypertrophy
(p < 0.001) (Fig. 6).
Left ventricular cavity dimensions were similar to those
of the other groups. Systolic anterior motion of the mitral
valve was present in 11 (39%) of the 28 patients and mid-
systolic closure of the aortic valve in 14 (66%) of 21 pa-
tients. Nine (32%) of the 28 patients had two of the classic
M-mode features and 16 (57%) had one of the features.
Discussion
Asymmetric septal hypertrophy. All of the 89 patients
studied had at least one myocardial region that was 1.5 em
or more in thickness. The original descriptions of hyper-
trophic cardiomyopathy highlighted the feature of hypertro-
phy as predominantly affecting the upper septum (10).
Whereas earlier M-mode studies (11,12) had confirmed
asymmetric septal hypertrophy, more recent work (2,3,6)
has shown that the upper septum may not, in fact, be dis-
proportionately thickened or even hypertrophied. In 49 (55%)
of our 89 patients, the predominant pattern of hypertrophy
was asymmetric septal hypertrophy. The distribution of hy-
pertrophy among these patients was similar to that reported
by Maron et al. (6). Hypertrophy was confined to the an-
terior and posterior septum in 35%, to the anterior septum
in 14% and involved both septum and free wall in 51%.
Although these 49 patients were identified as having the
"classic" form of the disease, 27 (55%) had a region of
the left ventricle that was thicker than the upper anterior
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Figure 4. Parasternal long-axis echocardiographic (left) and dia-
grammatic representation (right) of a patient with symmetric ven-
tricular hypertrophy, showing a small cavity and similarly in-
creased wall thickness in the septum and posterior wall . Abbreviations
as in Figure I.
septum and 9 (18%) did not have asymmetric hypertrophy
of the upper anterior septum.
Distal ventricular hypertrophy. Apical hypertrophic
cardiomyopathy is thought to be rare in Westernpopulations
(3,13). In our study, measurements of myocardial thickness
at the apex of the left ventricle were not reliable or repro-
ducible. Twelve (14%) of 89 patients, however, had left
ventricular hypertrophy that was predominantly in the distal
ventricle. From a two-dimensional echocardiographiceval-
uation, "distal ventricular" is a more appropriate term for
the findings in these patients. They had minimalhypertrophy
in the proximal ventricle, but in the distal ventricle hyper-
Figure 5. Short-axis mitral (left) and subpapillary (right) echo-
cardiograms in the same patient as in Figure 4, demonstrating
marked symmetric hypertrophy of the septum and posterior wall .
trophy was massive and the cavity was eliminated by huge
papillary muscles. M-mode echocardiography would not
have identified these patients, and the apparent rarity of this
form may reflect patient selection in Western population
studies (3,13).
Symmetric ventricular hypertrophy. In 28 patients
(31%), the left ventricular hypertrophy was symmetric. The
coefficient of variation for the measurements of wall thick-
ness was similar among the normal subjects and those with
symmetric hypertrophy. These patients exhibited a wide
spectrum of wall thickening, from those with 3.5 to 4.5 cm
thickness in all regions with severe cavity elimination to
those with thickness of only 1.5 em and near normal cavity
dimensions. We do not know whether this different expres-
sion of the condition reflectsvariable sensitivityto otherwise
minor stimuli for the development of hypertrophy (for ex-
ample, physiologic increases in afterload) or whether it is
due to some other factor.
Definition of asymmetric septal hypertrophy. In a pre-
vious analysis (6) of hypertrophy in hypertrophic cardio-
myopathy, 78% of patients had asymmetric septal hyper-
trophy with a septal to posteriorwall ratio of I .3:I or greater.
lACC Vol 2, No 3
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Figure 6. Coefficient of variation for measurements of left ven-
tricular wall thickness in 89 patients with hypertrophic cardio-
myopathy and 25 normal subjects. In patients with symmetric
hypertrophy and in the normalsubjects, the coefficient of variation
was less than 20%. In those with asymmetric septal hypertrophy
(ASH), the coefficient of variation was significantly greater (p <
0.001) and was less than 20% in only 6 (12%) of 49 patients. Of
these, five had mild to moderate hypertrophy (15 to 18 mm) lo-
calized to the upper anterior septum. The patients with distal ven-
tricular hypertrophy had minimal or no hypertrophy in the upper
ventricle. The pattern of hypertrophy in the lower ventricle was
asymmetric septal in six and symmetric in six; this distribution is
accuratelyreflected by the separationof the coefficient of variation
in these patients.
This degree of asymmetry , however, has been reported in
up to 44% of " normal" control subjects (9) , in 42% of
professional athletes (14) and in 30 to 70% of patients with
secondary left ventricular hypertrophy (15-18). A ratio of
1.5: I or greater is more likely to identify disproportionate
myocardial thickening. The discrepancy between the ob-
servations of Maron et al . (6) and our data in the proportion
of patients with asymmetric septal hypertrophy and sym-
metric hypertrophy is , in part (IO to 15%), due to a different
definition of asymmetry. The remaining difference (ap-
proximately 15%) may be due to patient selection .
At our institution before two-dimensional echocardiog-
raph y was available , the diagnosis of hypertrophic cardio-
myopathy was based on the characteristic clinical and an-
giographic features (7,8 ,19); M-mode echocardiography was
the primary diagnostic tool for only 4 of 289 patients . Al-
though Maron et al. (6) utilized both M-mode and two-
dimensional echocardiographic criteria , it seems probable
that their patient selection was influenced by their previous
M-mode experience, and their findings , therefore, favor
upper septal hypertrophy becau se of the limitations of the
M-mode technique when assessing the free wall , the pos-
terior septum and distal regions of the left ventricle .
Papillary muscle hypertrophy. Although it is well rec-
ognized that papillary muscle hypertrophy is common in
hypertrophic cardiomyopathy, there is no standardized method
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of quantitation. Acknowledging the limitations of the method
used , which will overestimate papillary muscle size when
the end-systolic cavity is small, only 3 patients were normal
and in 58 patients (65%) there was sufficient hypertrophy
to give the appearance of distal cavity elimination. Papillary
muscle hypertrophy was present in all the subgroups and it
seems that this is a consistent finding in hypertrophic
cardiomyopathy.
Reliability of two-dimensional echocardiography. At
present, two-dimensional echocardiography is the best method
for studying regional hypertrophy. Although most of the
heart may be examined using the different views, problems
remain with image resolution and the tendency to overes-
timate wall thickness and underestimate cavity size . Mea-
surements made at right angles to the ultrasound beam have
excellent reproducibility , but those requiring lateral reso-
lution (even if centered in the middle of the image) are less
reliable. It may also be difficult to identify endocardium
and epicardium, as is indicated by the unacceptable relia-
bility of measurements at the apex.
Clinical implications. Left ventricular hypertrophy in
hypertrophic cardiomyopathy can thus broadly be charac-
terized as having one of three distinct patterns. The criteria
to define these patterns are arbitrary and do not represent a
discontinuity of myocardial wall thickness ratios between
groups. It is uncertain whether these patterns identify
"subgroups" of patients with hypertrophic cardiomyopathy
of different origin. Our data show marked differences in the
degree and the distribution of hypertrophy within the groups,
as well as a continuity of myocardial wall thickness ratios
between the groups . It is important for the diagnosis of
hypertrophic cardiomyopathy to recognize that the degree
and distribution of hypertrophy are variable and that sym-
metric and distal ventricular hypertrophy are common and
not always amenable to M-mode echocardiographic diag-
nosis . It remains to be determined if identifiable patterns of
hypertrophy are of clinical or prognostic importance.
We thank J. F. Goodwin. MD and Cella Oakley, MD for their help and
permission to study the patients under their care.
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